MNG
Manning & Napier Group’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $17.7M | Sell |
258,118
-41,457
| -14% | -$2.84M | 0.2% | 93 |
|
|
2023
Q4 | $17.3M | Sell |
299,575
-1,277
| -0.4% | -$73.8K | 0.21% | 96 |
|
|
2023
Q3 | $15.9M | Sell |
300,852
-162,021
| -35% | -$8.55M | 0.2% | 104 |
|
|
2023
Q2 | $25M | Sell |
462,873
-5,326
| -1% | -$288K | 0.29% | 86 |
|
|
2023
Q1 | $23.4M | Buy |
468,199
+102,028
| +28% | +$5.1M | 0.27% | 86 |
|
|
2022
Q4 | $16.9M | Sell |
366,171
-39,647
| -10% | -$1.83M | 0.21% | 110 |
|
|
2022
Q3 | $15.7M | Sell |
405,818
-579
| -0.1% | -$22.4K | 0.21% | 113 |
|
|
2022
Q2 | $15.1M | Sell |
406,397
-25,186
| -6% | -$939K | 0.17% | 116 |
|
|
2022
Q1 | $19.1M | Sell |
431,583
-12,000
| -3% | -$531K | 0.18% | 117 |
|
|
2021
Q4 | $18.8M | Sell |
443,583
-880
| -0.2% | -$37.4K | 0.16% | 125 |
|
|
2021
Q3 | $19.3M | Sell |
444,463
-2,205
| -0.5% | -$95.7K | 0.17% | 118 |
|
|
2021
Q2 | $19.1M | Sell |
446,668
-13,931
| -3% | -$596K | 0.16% | 127 |
|
|
2021
Q1 | $17.8M | Buy |
460,599
+31,853
| +7% | +$1.23M | 0.15% | 136 |
|
|
2020
Q4 | $15.4M | Buy |
428,746
+44,862
| +12% | +$1.61M | 0.14% | 136 |
|
|
2020
Q3 | $14.7M | Sell |
383,884
-5,641
| -1% | -$216K | 0.15% | 122 |
|
|
2020
Q2 | $13.7M | Buy |
389,525
+15,369
| +4% | +$540K | 0.15% | 125 |
|
|
2020
Q1 | $12.2M | Sell |
374,156
-121,225
| -24% | -$3.96M | 0.14% | 117 |
|
|
2019
Q4 | $22.4M | Sell |
495,381
-40,095
| -7% | -$1.81M | 0.24% | 96 |
|
|
2019
Q3 | $21.8M | Sell |
535,476
-70,410
| -12% | -$2.86M | 0.24% | 99 |
|
|
2019
Q2 | $26M | Buy |
+605,886
| New | +$26M | 0.28% | 90 |
|